The stigma associated with contracting a sexually transmitted disease was originally perpetrated within the health care system as early as the 16th century and subsequently reinforced in the wider society.
Eitan Neidich, Alon B. Neidich, David A. Axelrod, MD, and John P. Roberts, MD
Geographic disparities in availability of organs for transplant have spawned for-profit companies that help patients get on waitlists in more than one region and arrange travel for them if an organ becomes available.
Chromosomal microarray analysis reveals many gene variants of unknown significance. The uncertainty about these variants—might they be deleterious or are they benign?—complicates genetic counseling.
Some disability advocates take issue with the “normalization” goals of the medical model of rehabilitation, but expressions of that position can be dismissive of rehabilitationists’ efforts to remediate oppressive functional deficits.
AMA J Ethics. 2015;17(6):562-567. doi:
10.1001/journalofethics.2015.17.6.msoc1-1506.
The American Medical Association Code of Medical Ethics’ opinions on physicians’ self-referral and physicians’ sale of health-related and non-health-related products from their offices.
AMA J Ethics. 2015;17(8):739-743. doi:
10.1001/journalofethics.2015.17.8.coet1-1508.
Aaron Wightman, MD, MA and Douglas Diekema, MD, MPH
In making decisions about allocating scarce organs, undocumented immigrant status should not be used as a proxy for the legitimate criterion of likelihood of success because uncertainty about future ability to pay or insurance coverage applies to almost everyone listed for transplant.
AMA J Ethics. 2015;17(10):909-913. doi:
10.1001/journalofethics.2015.17.10.peer1-1510.